Addex Therapeutics Statistics
NASDAQ: ADXNHealthcareBiotechnologyUSD
3.18+0.2027 (+6.81%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Addex Therapeutics by the numbers
Addex Therapeutics has a market capitalization of $5.6 million based on 1.75M shares outstanding. With trailing EPS of $-7.44, Addex Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.1% below its 50-day average and 49.0% below its 200-day average.
Average daily trading volume is 138.01K shares, or about $438,885 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ADXN valuation vs. peer median
| Metric | ADXN | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.57M | $5.55M | +0% |
| Avg. volume | 138.01K | 284.60K | -52% |
Peer median across 8 companies: PULM, ENLV, CDIO, KALA, DRMA, IMNN, CANF, LNAI.
Valuation
- Market cap
- $5.57M
- EPS (TTM)
- $-7.44
- Shares outstanding
- 1.75M
Price and trading
- Previous close
- 2.98
- Open
- 3.22
- Day range
- 3.00 – 3.23
- 52-week range
- 2.56 – 11.97
- Beta
- —
- Volume
- 11.64K
- Average volume
- 138.01K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Sep 1, 2025
Additional statistics
- Market Cap
- 5.57M
- Forward Pe
- -63.60
- Eps
- -7.44
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.97
- Week52 Low
- 2.56
- Avg Volume
- 138.01K
- Shares Outstanding
- 1.75M
- Ma50
- 4.24
- Ma200
- 6.23
- Earnings Date
- Sep 1, 2025
- Pct From52w High
- -73.43%
- Pct From52w Low
- 24.22%